News
Merck KGaA, Darmstadt, Germany (DAX: MRK), a leading science and technology company, and SpringWorks Therapeutics, Inc.
Merck KGaA has announced that it will be acquiring SpringWorks Therapeutics for approximately $3.9bn. The definitive ...
The latest health-related developments include Merck's acquisition talks with SpringWorks, disbandment of a US Justice ...
3d
DPA International on MSNGerman pharma giant Merck close to takeover of US cancer specialistGermany's Merck is on the verge of a billion-euro takeover of US biopharmaceutical company Springworks Therapeutics, with the ...
Barclays notes that SpringWorks Therapeutics’ Ogsiveo was included on today’s Committee for Medicinal Products for Human Use agenda, which could lead to a positive opinion for ...
Gilead Sciences reports profits but mixed revenue; Merck is in talks to acquire SpringWorks for $3.5 billion; measles cases ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results